Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count)
Background. We performed prospective validation of the cancer ratio (serum LDH : pleural ADA ratio), previously reported as predictive of malignant effusion retrospectively, and assessed the effect of combining it with “pleural lymphocyte count” in diagnosing malignant pleural effusion (MPE). Method...
Saved in:
Main Authors: | Akash Verma, Rucha S. Dagaonkar, Dominic Marshall, John Abisheganaden, R. W. Light |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2016/7348239 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identifying malignant pleural effusion from tubercular pleural effusion by study of cancer ratio and cancer ratio plus
by: Subhankar Saren, et al.
Published: (2025-02-01) -
Management of Malignant Pleural Effusions with Indwelling Pleural Catheters or Talc Pleurodesis
by: Nadim Srour, et al.
Published: (2013-01-01) -
Malignant Pleural Effusion: Diagnosis and Management
by: Lucía Ferreiro, et al.
Published: (2020-01-01) -
Pleural Fluid Cholesterol in Differentiating Exudative and Transudative Pleural Effusion
by: A. B. Hamal, et al.
Published: (2013-01-01) -
Management of Malignant Pleural Effusion with ASEPT® Pleural Catheter: Quality of Life, Feasibility, and Patient Satisfaction
by: Inderdeep Dhaliwal, et al.
Published: (2016-01-01)